Patient preferences for chemotherapies used in breast cancer

  title={Patient preferences for chemotherapies used in breast cancer},
  author={Kathleen Marie Beusterien and Jessica L Grinspan and Thomas Tencer and Adam M. Brufsky and Constance Visovsky},
  booktitle={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
e19667 Background: New therapies are being developed for advanced breast cancer that may not be curative, but may be associated with an incremental advantage in survival relative to existing therapies. This increase in survival duration should be weighed against the risk of toxicities when making treatment decisions. The objective of this study was to assess the trade-offs patients are willing to make among efficacy, administration regimen, and risk of toxicities among available advanced breast… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-7 of 7 extracted citations

A descriptive review on methods to prioritize outcomes in a health care context

Health expectations : an international journal of public participation in health care and health policy • 2015


Publications referenced by this paper.
Showing 1-10 of 16 references

Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2011

Patient reported outcomes in chemotherapy-induced peripheral neuropathy: A review

M Sasane, T Tencer, A French, T Maro, KM. Beusterien
J Support Oncol • 2010

Treatments in common use for metastatic breast cancer

M. Mayer
Available from: Accessed June • 2010
View 1 Excerpt

of Health & Human Services

US Departmen
Health Information Privacy. Available from: Accessed June 1, • 2010
View 2 Excerpts